New Poster: Probabilistic prediction of human skin sensitiser potency for use in Next Generation Risk Assessment (NGRA)

Our Skin Allergy Risk Assessment Defined Approach (SARA DA) model (Reynolds et al. 2019) is shown applied to a hypothetical Next Generation Risk Assessment (NGRA) case study – use of 0.1% coumarin in a face cream. We describe how the SARA DA model can be used as part of a weight of evidence approach to derive a point of departure from in vitro data and make a risk assessment decision.

View the poster here.

Share

Comments are closed.